Wordt geladen...
Relapsed small cell lung cancer: treatment options and latest developments
According to recent analyses, there was a modest yet significant improvement in median survival time and 5-year survival rate of limited stage small cell lung cancer (SCLC) in North America, Europe, Japan and other countries over the last 30 years. The median survival time of limited stage SCLC is 1...
Bewaard in:
Hoofdauteurs: | , , , , |
---|---|
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
SAGE Publications
2014
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3932054/ https://ncbi.nlm.nih.gov/pubmed/24587832 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834013517413 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|